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Aims of Genetic Epidemiology 
• Quantify the genetic contribution to a disease or trait 
– “Nature vs Nurture” 
• Find the gene(s) that cause a disease 
 
• Measure the effect of each gene 
– Within groups of relatives 
– Compare between populations 
– Interactions with environmental factors 
 
How can genetics help us? 
• Understanding disease 
– Etiology – what are the biological pathways to disease? 
– Distribution – which groups of people are at greater risk? 
– Control – how could we limit the impact of disease? 
• New targets for treatment 
– Drug targets in novel pathways 
– Distribution & evolution of pathogens 
• Personalised Medicine 
– Which treatments work on which people 
– Preventing adverse drug reactions 
– Predicting disease risks much earlier in life 
• Forensics 
• Genealogy 
 
Genetic vs Mainstream Epidemiology 
• A gene is an “exposure” / “treatment” / “intervention” / etc 
• How do genes differ from variables that are usually studied? 
 
Genetic vs Mainstream Epidemiology 
• A gene is an “exposure” / “treatment” / “intervention” / etc 
• How do genes differ from variables that are usually studied? 
– Not modifiable: can only intervene on downstream effects 
– Fixed at conception  
• Can measure after disease has occurred 
• Clear causal path from gene to disease 
– Easy to measure 
• Selection bias & confounding less of a problem 
 


Gregor Mendel (1822-1884) 
• In 1860 developed theory for inheritance based on 
statistical analysis of data collected for garden pea plant 
 
• Mendel’s cross pollination used statistical approach to 
reveal effects of crossing different strains of the common 
garden pea 
Mendel: Experiments on Plant Hybridization 
Mendel: Experiments on Plant Hybridization 

Mendel’s first law 
• Law of segregation: Two copies of a gene have an equal 
probability of being transmitted (segregating) to an 
offspring 
 
50% 50% 
Mendel’s second law 
• Law of independent assortment: each gene is 
distributed randomly and independently from genes 
for other characteristics 
– “Random allocation at conception” independent of 
confounders 
25% 25% 25% 25% 

Francis Galton (1822 – 1911) 
 
 
 
 
 
 
• Studied continuous traits, like height 
• Child height well predicted by average of parents 
• Child between mid-parents and population mean 
 
Galton vs Mendel 
Mendel Galton 
Discrete traits Continuous traits 
Genes inherited intact with 
dominant/recessive action 
Traits inherited directly from 
parents 
Trait could skip a generation “Blending” of traits from 
parents 
Medical genetics Quantitative/behavioural 
genetics 
Experimental genetics Genetic epidemiology 

R. A. Fisher (1890 – 1962) 
Biometrical model 
• Fisher showed that continuous traits can arise from 
combination of multiple “genes” inherited in Mendelian 
fashion 
• Also known as polygenic model, especially when applied to 
disease traits (with continuous risk or liability) 
• Introduced the term “variance” which has genetic and 
environmental components 
• Reconciles Mendel vs Galton 
Classes of genetic disease 
• Monogenic 
– Clear phenotype 
– Mendelian 
• Oligogenic 
– Variable phenotype 
– Genetic heterogeneity 
• Polygenic 
– ‘continuous’ phenotype 
– Complex traits 
– Multifactorial 
– extensive heterogeneity 
Janssens A. and van Duijn C, Hum Mol Genet 2008 
Figure 3. Complete cause models or sufficient causes of disease 
development. 
Complete causal models for (A) Huntington Disease; (B) 
Phenylketonuria; 
(C–F) Hypothetical examples for complex diseases. White areas 
refer to 
genetic factors and grey areas to environmental factors. 
Study Design in Genetic Epidemiology 
Familial Risk/Heritability 
- Families, Twin studies, Migrant, Half Sibling, Adoption 
studies 
 
Mapping 
- Families with multiple affected 
- Case/control, cohort, parent-child “trios” 
Collaborative Group on Hormonal factors in Breast Cancer, Lancet, 2001  
Family history and risk of breast cancer 
Twin concordances 
1 Nussbaum, R. L., McInnes, R. R., & Willard, H.F. (2004). Genetics of 
Disorders with Complex Inheritance. In Thompson & Thompson (Eds.), 
Genetics in Medicine. 6th edition.(p.293) Philadelphia : Saunders.  
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Cancer rates in Japanese migrants become similar 
to those in the local US population  
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Sporadic or genetic? 
What is the genetic 
model? 
Where in the 
genome is the 
disease locus? 
Fine-map the 
locus. 
Identify the gene Find the 
mutation 
The path to gene 
discovery in 
human genetic 
disease 
Linkage 
• Sometimes two traits don’t follow Mendel’s 2nd law 
• These traits – or the genes for them – are said to be 
linked 
• They are inherited together within families 
Linkage analysis 
Is the co-segregation of the marker allele A1 with the disease 
phenotype due to random chance* or is the marker linked to the 
disease locus? 
M  m 
M  m 
M  m M  m M  m 
m  m 
m  m m  m 
m  m 
M = mutation 
m = normal 
*probability, p-values etc 
Finding disease genes 
• Linkage analysis worked well for monogenic Mendelian 
diseases 
• Not so good for complex diseases 
– Diabetes, heart disease, schizophrenia etc 
• For complex diseases, it is better to use association 
analysis based on linkage disequilibrium (LD) 
• Genes that are close on a chromosome tend to be 
correlated in the population 
• Standard tests of association for genes and disease 
– Chi-squared tests, linear regression etc 
Linkage disequilibrium 
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Common ancestry leads to present-day correlation at short ranges 
Association between disease and genetic marker  marker is close to 
disease gene 
Genomewide association scan (GWAS) 
• A single nucleotide polymorphism (SNP) is a DNA “letter” 
which varies between individuals 
• Ideally we would test every SNP for association to disease, 
but this is too expensive 
• Instead we select a subset of SNPs in the hope that causal 
variants will be in linkage disequilibrium with them 
• Current GWAS use 1M SNPs 
– At least 10M SNPs in the human genome 
Draft human genome in 2001 
Tells us about an “average” human 
Doesn’t tell us about differences between humans 
-  Particularly why some get disease when others don’t 
HapMap in 2005 
Catalogue of genetic variation in 4 populations 
 
Allows design of genomewide panel of markers 
for association studies 
 
Ongoing: now 11 populations 
www.hapmap.org 
Genome-wide variation is a rich source of information 
Novembre et al., Nature 
456:98-101 (2008) 
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Teri Manolio 
Published Genome-Wide Associations through 07/2012 
Published GWA at p≤5X10-8 for 18 trait categories 
NHGRI GWA Catalog 
www.genome.gov/GWAStudies 
www.ebi.ac.uk/fgpt/gwas/  
Coming soon 
April 2008 
Linkage mapping 
Mendelian disease 
•Huntingdon’s 
•Haemophilia Fine mapping 
•Cystic Fibrosis 
Whole genome linkage scan 
•Type-1 diabetes 
Human 
Genome 
Project 
HapMap 
Genomewide Association 
Complex disease 
•Type-2 diabetes 
•Heart Disease 
•Schizophrenia 
Sequencing 
1970 1980 1990 2000 2010 
SNPs STRs 
Summary 
• In the last 20 years, genetics has evolved from “difficult” 
analyses of pedigrees to “standard” epidemiological methods 
– This resulted from rapid advances in genotyping technology and 
knowledge of the human genome 
 
• Currently enormous effort & expenditure on finding the 
hundreds of genes that explain common diseases 
 
• These discoveries will lead to better understanding of disease 
etiology, more accurate population screening, and 
opportunities for personalised medicine 
 
